semaglutide type 1 diabetes trial Efficacy and safety of once-weekly monotherapy versus placebo in patients with 2 (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a ADA 2025 Recap: Improving Lives
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5






























